Trial site
LUX MED Onkologia Sp. z.o.o.
- 18running trials
- 9closed trials
The trials here
What the 27 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer6 trials
- Kidney cancer5 trials
- Metastatic breast cancer4 trials
- Pancreatic cancer4 trials
- Bladder cancer3 trials
- Prostate cancer3 trials
- Gastric and oesophageal cancer2 trials
- Lung cancer2 trials
- Myeloproliferative neoplasms2 trials
- Ovarian cancer2 trials
- Follicular lymphoma1 trial
- Melanoma1 trial
- and 1 more
- Phase
- Phase 315 trials
- Phase 27 trials
- Phase 13 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting9 trials
- Completed8 trials
- Recruiting6 trials
- Not yet recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Merck Sharp & Dohme LLC7 trials
- Astellas Pharma Global Development, Inc.2 trials
- Bristol-Myers Squibb2 trials
- Celcuity Inc2 trials
- MacroGenics2 trials
- and 11 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer4 recruiting
- Pancreatic cancer4 recruiting
- Kidney cancer2 recruiting
- Ovarian cancer2 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Terminated
RVU120 in Patients With Intermediate or High-risk, Primary or Secondary Myelofibrosis
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026